SCHEMBL173417

SCHEMBL173417

O=C1[CH]NCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20268545 0.76
SCHEMBL89327 0.59
SCHEMBL179067 0.59
SCHEMBL1335595 0.59
Methane SCHEMBL595114 0.57
SCHEMBL11207122 0.57 ALDH1A1 (0.48)
SCHEMBL11206389 0.57 ALDH1A1 (0.48)
SCHEMBL31053064 0.57
SCHEMBL12158699 0.57
Hydrochloric Acid SCHEMBL30227166 0.57 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066647-B1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2011-11-09 EP claimed
US-20100009978-A1 Benzoxazoles and Oxazolopyridines Being Useful as Janus Kinases Inhibitors NOVARTIS AG 2010-01-14 US claimed
CN-101516860-A Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors NOVARTIS AG (CH) 2009-08-26 CN claimed
EP-2066647-A1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS Novartis AG (CH) 2009-06-10 EP claimed
WO-2008031594-A1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2008-03-20 WO claimed
EP-3400253-B1 DITHIOPHENETHIADIAZOLE SEMICONDUCTORS AND RELATED DEVICES FLEXTERRA INC (US) 2023-10-04 EP disclosed
US-20220273629-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTOR TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) 2022-09-01 US disclosed
EP-4007574-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTOR Aptinyx Inc. (US) 2022-06-08 EP disclosed
US-11345778-B2 Organic dielectric materials and devices including them FLEXTERRA, INC. (US) 2022-05-31 US disclosed
WO-2021021996-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTOR APTINYX INC. (US) 2021-02-04 WO disclosed
EP-3740523-A1 ORGANIC DIELECTRIC MATERIALS AND DEVICES INCLUDING THEM Flexterra, Inc. (US) 2020-11-25 EP disclosed
US-10840453-B2 Dibromo-diiodo-dipolycyclic compound and electron acceptor molecules derived therefrom INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-11-17 US disclosed
US-20080161524-A1 Photopolymer-based dielectric materials and methods of preparation and use thereof USINVEST LLC 2008-07-03 US disclosed
WO-2008066622-A2 SEMICONDUCTING SILOXANE COMPOSITIONS FOR THIN FILM TRANSISTOR DEVICES, AND MAKING AND USING THE SAME NORTHWESTERN UNIVERSITY (US) 2008-06-05 WO disclosed
WO-2008066826-A1 PHOTOPOLYMER-BASED DIELECTRIC MATERIALS AND METHODS OF PREPARATION AND USE THEREOF POLYERA CORPORATION (US) 2008-06-05 WO disclosed
WO-2008063583-A1 ACENE-BASED ORGANIC SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME POLYERA CORPORATION (US) 2008-05-29 WO disclosed
WO-2008063609-A2 DIIMIDE-BASED SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USING THE SAME POLYERA CORPORATION (US) 2008-05-29 WO disclosed
WO-2008039414-A1 PROCESS FOR THE PREPARATION OF 4-HYDROXYTHIENO[2,3-B]PYRIDINE-5-CARBONITRILES WYETH (US) 2008-04-03 WO disclosed
US-20080076926-A1 Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles WYETH 2008-03-27 US disclosed
WO-2008031594-A1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2008-03-20 WO disclosed